Nature News
Revolutionary drug for schizophrenia wins US approval
‘Afraid to talk’: researchers fear the end for science in Venezuela
Daily briefing: Bigger chatbots tell more lies
Satellites are photobombing astronomy data — could AI offer a solution?
1995: Revealing the most common cause of early-onset Alzheimer’s disease
1906: The dawn of Alzheimer’s disease
1985: Disentangling tau pathology
This fish’s legs are made for walking — and tasting the sea floor
Stem cells reverse woman’s diabetes — a world first
Researchers in Hungary raise fears of brain drain after ‘body blow’ EU funding suspension
2013: Genetic risk factors for Alzheimer’s uncovered by large meta-analysis
1993: A major genetic risk factor for late-onset Alzheimer’s disease
My mission to protect threatened mangroves
Carbon bond that uses only one electron seen for first time: ‘It will be in the textbooks’
1984: Identifying amyloid-β in brain plaques
1999: A vaccine raises hopes of treatment for Alzheimer’s disease
2008: Exploring the role of inflammation and immunity in Alzheimer’s disease
1987: Finding the first Alzheimer’s gene
2020: A blood-borne biomarker for Alzheimer’s disease
2021: Anti-amyloid antibodies take a bumpy road to the clinic
Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.
Subscribe to Nature News feed